The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By

October 27, 2020 at 09:13

The Can B Corp. (OTCQB: CANB) advantage: lab tested certification of hemp-sourced products, from Hemp Oils To CBD Gels, is a proven success. Documenting hemp-sourced CBD product quality is a winner in fast-growing CBD industry seen reaching $30 billion at retail by 2023 projects Marijuana Business Daily as it achieves legal status in more states. Can B Corp. (OTCQB: CANB) is growing market share in this fast-growing industry with strategies of achieving seed-to-sale status, branding product, multi-channel selling and the vital lab-testing certification of its products for consumers and retailers. The Company offers 'Certificates Of Analysis' (COA's) to document QC for its products in this relatively new industry now going mainstream.

The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Cronos Group (NASDAQ: CRON), Canopy Growth Corp. (NYSE: CGC), Charlotte's Web (CSE: CWEB), INSYS Therapeutics, Inc. (NASDAQ: INSY), cbdMD (NYSE: YCBD), Joy Organics (NASDAQ: JOYG),, GW Pharmaceuticals (NASDAQ: GWPH) and Supreme Cannabis Co. (OTC: SPRWF).

The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023

CBD legalization is on the ballot during Election Day next week in several states. Already, cannabis has been legalized in 27 U.S. states. Can B Corp. (OTCQB: CANB) has been aggressively expanding its product lines. It offers CBD products under the brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It markets to multi-channels including medical offices, doctor's offices, retailers, online and direct. The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023

Can B Corp. (OTCQB: CANB): An Advantage Is Its Third Party Lab Test Certification Of Hemp-Sourced Products

This developing health and wellness company offers product through diverse marketing strategies: proprietary licensed brands, white labels, private labels through third parties and distribution through various channels such as retail, professional (physician), direct sales through its website and sales through subsidiaries. The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023.

Can B Corp.'s (OTCQB: CANB) Advantage Is Its Comprehensive Documentation Of QC For Its Supplements And Nutritional Products

A driving issue that separates its product from others is its comprehensive documentation of product quality. "All supplements and nutritional products distributed by us are laboratory tested in multiple facilities by third parties to ensure purity, safety and consistency -- we retain the test results to prove it," the Company's Pure Leaf Oil website reports. "Clients located outside of areas with relaxed state cannabis laws should confirm that their hemp supplements are imported from a reputable source of industrial hemp." It adds: "Upon request, we can readily provide our clients with certificates of analysis (COA's) for all the products we distribute."

It offers examples of the certificates of analysis for Canbiola-branded hemp sourced extracts of Nano Drops, Extract Sprays, CryoGels and Pre-Roll Cherry Wine. The certificates based on third party independent lab tests give specifics of Microbiological counts and Cannabinoid Profile and Potency. Can B Corp. (OTCQB: CANB) continues to introduce new product and maintains its profitability during the pandemic.

Marco Alfonsi, CEO, is optimistic about the future financial performance of Can B Corp. (OTCQB: CANB) due in part to the strong gross margins of almost 77% the CBD company has achieved. In a report by site Bloomberg on CAN B Corp.'s (OTCQB: CANB) Q2 2020 financial results, the Company reported in the three month period ended June 30, 2020 that its gross profits rose 24% to 77% in 2020 from 53% in the comparable period in 2019. The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023.

Strong Gross Margins Of Almost 77% Help Drive Can B Corp.'s (OTCQB: CANB) Marco Alfonsi, CEO, Optimism About The Company's Financial Performance As Hemp-Derived CBD Products Soar

Marco Alfonsi, CEO of Can B Corp. (OTCQB: CANB), said, "We remain enthusiastic about our business prospects and returning to growth mode. Given our strong gross margins of almost 77%, -- 76.6% -- we feel confident in being able to return to the position we were earlier in 2020 when our revenue growth outpaced growth in expenses, as we achieved operating efficiencies." The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023.

A Projection Of $30 Billion By 2023 For CBD Industry

Can B Corp. (OTCQB: CANB) is reporting gross profitability in a competitive, fast-growing CBD industry seen as hitting $30 billion at retail by 2023, according to a projection by Marijuana Business Daily. The Can B Corp. (OTCQB: CANB) Advantage: Lab Tested Certification Of Hemp-Sourced Products, From Hemp Oils To CBD Gels; Marketing Strategy Of Documenting Product Quality Proves Successful In Fast-Growing CBD Industry Seen Hitting $30 Billion At Retail By 2023.

A Health And Wellness Emerging Growth Company

Can B Corp. (OTCQB: CANB) offers an extensive line of drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. This health and wellness emerging growth company offers lines of hemp derived CBD, CBD and non-CBD under license for the Lifeguard(R) lifestyle brand, Canbiola branded through physicians, products through white label and private label plus other subsidiaries.

Can B Corp. (OTCQB: CANB) Offers An Extensive Line Of CBD Products

Source: Stock Market Press

Join Stock Market Press' newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be "forward-looking statements." Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press

comtex tracking

COMTEX_373475931/2718/2020-10-27T09:13:40

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.